Dr Lucy Furfaro

Experts / Dr Lucy Furfaro

NHMRC Emerging Leadership Fellow, The University of Western Australia

Dr Furfaro is a NHMRC Emerging Leadership Fellow within the Medical School, Division of Obstetrics and Gynaecology. As a microbiologist, she is interested in microbes in the context of pregnancy and early life. Her research explores targeted antibiotic alternatives such as bacteriophage therapy to treat leading neonatal pathogens such as Group B Streptococcus. Lucy has a strong discovery to translation focus to her research and is an active science communicator.

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

By Christine Carson, Dr Lucy Furfaro

Clinical Articles

Infectious diseases

Dr Lucy Furfaro

NHMRC Emerging Leadership Fellow, The University of Western Australia

More from this expert

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Dr Lucy Furfaro

NHMRC Emerging Leadership Fellow, The University of Western Australia

More from this expert

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.